Cargando…

Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine

Virulent strains of Newcastle disease virus (NDV) can cause devastating disease in chickens worldwide. Although the current vaccines are substantially effective, they do not completely prevent infection, virus shedding and disease. To produce genotype-matched vaccines, a full-genome reverse genetics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Shin-Hee, Wanasen, Nanchaya, Paldurai, Anandan, Xiao, Sa, Collins, Peter L., Samal, Siba K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755997/ https://www.ncbi.nlm.nih.gov/pubmed/24015313 http://dx.doi.org/10.1371/journal.pone.0074022

Ejemplares similares

Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2017)

Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine
por: Manoharan, Vinoth K., et al.
Publicado: (2018)

Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens
por: Kim, Shin-Hee, et al.
Publicado: (2014)

Sequence analysis of fusion protein gene of Newcastle disease virus isolated from outbreaks in Egypt during 2006
por: Mohamed, Mahmoud HA, et al.
Publicado: (2011)

Effects of Naturally Occurring Six- and Twelve-Nucleotide Inserts on Newcastle Disease Virus Replication and Pathogenesis
por: Paldurai, Anandan, et al.
Publicado: (2014)

Retraction: Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine
Publicado: (2020)

Complete Genome Sequence of a Highly Virulent Newcastle Disease Virus Currently Circulating in Mexico
por: Xiao, Sa, et al.
Publicado: (2013)

A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2018)

Author Correction: A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2020)

Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain
por: Xiao, Sa, et al.
Publicado: (2012)

Correction: Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain
por: Xiao, Sa, et al.
Publicado: (2022)

Contributions of HA1 and HA2 Subunits of Highly Pathogenic Avian Influenza Virus in Induction of Neutralizing Antibodies and Protection in Chickens
por: Shirvani, Edris, et al.
Publicado: (2020)

A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge
por: Shirvani, Edris, et al.
Publicado: (2020)

Author Correction: A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge
por: Shirvani, Edris, et al.
Publicado: (2020)

Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2019)

Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2016)

Complete Genome Sequence of an Avian Paramyxovirus Type 4 from North America Reveals a Shorter Genome and New Genotype
por: Parthiban, Manoharan, et al.
Publicado: (2013)

Complete Genome Sequence of Avian Paramyxovirus (APMV) Serotype 5 Completes the Analysis of Nine APMV Serotypes and Reveals the Longest APMV Genome
por: Samuel, Arthur S., et al.
Publicado: (2010)

Evaluation of the Replication, Pathogenicity, and Immunogenicity of Avian Paramyxovirus (APMV) Serotypes 2, 3, 4, 5, 7, and 9 in Rhesus Macaques
por: Khattar, Sunil K., et al.
Publicado: (2013)

Development of a recombinant Newcastle disease virus-vectored vaccine for infectious bronchitis virus variant strains circulating in Egypt
por: Abozeid, Hassanein H., et al.
Publicado: (2019)

Novel avian paramyxovirus-based vaccine vectors expressing the Ebola virus glycoprotein elicit mucosal and humoral immune responses in guinea pigs
por: Yoshida, Asuka, et al.
Publicado: (2019)

Role of fusion protein cleavage site in the virulence of Newcastle disease virus
por: Panda, Aruna, et al.
Publicado: (2004)

Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2
por: Shirvani, Edris, et al.
Publicado: (2020)

Protective efficacy of the Newcastle disease virus genotype VII–matched vaccine in commercial layers
por: Sultan, Hesham A., et al.
Publicado: (2020)

Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1
por: Khattar, Sunil K., et al.
Publicado: (2010)

Expression of Concern: Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines
Publicado: (2020)

Co-expression of the Hemagglutinin and Neuraminidase by Heterologous Newcastle Disease Virus Vectors Protected Chickens against H5 Clade 2.3.4.4 HPAI Viruses
por: Cho, Yeonwoo, et al.
Publicado: (2018)

Mutations in the Fusion Protein Cleavage Site of Avian Paramyxovirus Serotype 4 Confer Increased Replication and Syncytium Formation In Vitro but Not Increased Replication and Pathogenicity in Chickens and Ducks
por: Kim, Shin-Hee, et al.
Publicado: (2013)

Generation of porcine reproductive and respiratory syndrome virus by in vitro assembly of viral genomic cDNA fragments
por: Suhardiman, Maman, et al.
Publicado: (2015)

Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2013)

Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus
por: Manoharan, Vinoth K., et al.
Publicado: (2018)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2014)

Genotype-matched Newcastle disease virus vaccine confers improved protection against genotype XII challenge: The importance of cytoplasmic tails in viral replication and vaccine design
por: Izquierdo-Lara, Ray, et al.
Publicado: (2019)

Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans
por: DiNapoli, Joshua M., et al.
Publicado: (2009)

Efficacy of the Newcastle Disease Virus Genotype VII.1.1-Matched Vaccines in Commercial Broilers
por: Sultan, Hesham A., et al.
Publicado: (2021)

Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
por: DiNapoli, Joshua M., et al.
Publicado: (2010)

Protection against Different Genotypes of Newcastle Disease Viruses (NDV) Afforded by an Adenovirus-Vectored Fusion Protein and Live NDV Vaccines in Chickens
por: Ferreira, Helena L., et al.
Publicado: (2021)

Immunization of Chickens with Newcastle Disease Virus Expressing H5 Hemagglutinin Protects against Highly Pathogenic H5N1 Avian Influenza Viruses
por: Nayak, Baibaswata, et al.
Publicado: (2009)

A Booster with a Genotype-Matched Inactivated Newcastle Disease Virus (NDV) Vaccine Candidate Provides Better Protection against a Virulent Genotype XIII.2 Virus
por: Hossain, Ismail, et al.
Publicado: (2023)

SARS-CoV-2 Delta (B.1.617.2) variant replicates and induces syncytia formation in human induced pluripotent stem cell-derived macrophages
por: Thaweerattanasinp, Theeradej, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cii9rbh1ffbfo1kr27apfl7ose